New embolization treatment aims to ease knee pain without surgery
NCT ID NCT06930677
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new procedure called musculoskeletal embolization using NBGM200 to treat knee osteoarthritis. The goal is to reduce pain and improve function and quality of life. The trial will enroll 72 adults with knee OA confirmed by MRI. Participants will receive the embolization treatment and be followed for changes in pain and knee health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
embolization procedure using NBGM200
What this could lead to
If it works, this could offer a new, non-surgical option to reduce pain and improve knee function in people with knee osteoarthritis.
What could go wrong
This is an early, single-arm study with only 72 participants, so results may not apply to everyone. The procedure carries risks like infection or complications from embolization.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS (KNEE OA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Elisabeth-Tweesteden Hospital
RECRUITINGTilburg, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Ghent
RECRUITINGGhent, Belgium
Contact
Contact Phone: •••-•••-••••
-
Uz Leuven
RECRUITINGLeuven, Belgium
Contact Phone: •••-•••-••••